- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
LivaNova PLC (LIVN)
LivaNova PLC stock price live, this page displays NASDAQ LIVN stock exchange data. View the LIVN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the LivaNova PLC real time stock price chart below.
What Is the LivaNova PLC Stock Price Today?
The LivaNova PLC stock price today is 75.68.
What Is the Stock Symbol for LivaNova PLC?
The stock ticker symbol for LivaNova PLC is LIVN.
Is LIVN the Same as $LIVN?
$LIVN is a common way to refer to the LivaNova PLC ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does LivaNova PLC Trade On?
LivaNova PLC is listed and trades on the NASDAQ stock exchange.
Is LivaNova PLC a Good Stock to Buy?
Determining whether LivaNova PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current LivaNova PLC share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LIVN quote. (ISIN: GB00BYMT0J19)
What Is the LivaNova PLC Stock Price Today?
The LivaNova PLC stock price today is 75.68.
What Is the Stock Symbol for LivaNova PLC?
The stock ticker symbol for LivaNova PLC is LIVN.
Is LIVN the Same as $LIVN?
$LIVN is a common way to refer to the LivaNova PLC ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does LivaNova PLC Trade On?
LivaNova PLC is listed and trades on the NASDAQ stock exchange.
Is LivaNova PLC a Good Stock to Buy?
Determining whether LivaNova PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current LivaNova PLC share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LIVN quote. (ISIN: GB00BYMT0J19)
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
75.68
75.68
52 wk Range
48.82
85.76
LIVN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
75.6875.68
52 wk Range
48.8285.76
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
LIVN Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
89.10
Upside
+17.73%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
7 analysts have revised their earnings downwards for the upcoming period
LivaNova PLC receives Investment Bank Analyst Rating Update- Investing.com
Pro
- LivaNova PLC receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
LivaNova PLC receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Analyst Ratings
8 Buy
2 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 89.10
(+17.73% Upside)
LivaNova PLC SWOT Analysis
Operational Momentum | Third quarter organic growth of 12.5 percent demonstrates strong execution in Cardiopulmonary Support and Epilepsy segments, significantly exceeding industry benchmarks |
Analyst Outlook | Price target stands at $58 from Barclays, with earnings projections of $3.82 for fiscal 2026 and $4.04 for fiscal 2027, reflecting growth expectations |
Market Expansion | The company's planned 2027 obstructive sleep apnea system launch addresses a market of millions of patients, diversifying revenue beyond cardiopulmonary and epilepsy solutions |
Growth Blueprint | LivaNova unveils five-year plan targeting high single-digit sales growth and operating margins in the high-20 percent range through core business expansion |
LivaNova PLC Earnings Call Summary for Q2/2026
- LivaNova reported Q2 adjusted EPS of $1.26, beating estimates by 15.6%, with revenue of $390.6M exceeding forecasts by 2.64%.
- Company raised FY2026 guidance: revenue growth to 8-9% from 7-8%, adjusted EPS to $4.30-$4.40, reflecting double-digit segment growth.
- Cardiopulmonary revenue rose 10% to $222M; oxygenator market share expanded to 40% from 30%, supported by Thermo Fisher supply agreement.
- Capital spending increased to $135M from $120M for capacity expansion; free cash flow guidance lowered to $140-160M from $160-180M.
- OSA PMA supplement submission delayed to H2 2026-H1 2027; management cited verification work, not safety concerns, as cause for timeline shift.
Last Updated: 08/05/2026, 09:21 AM
Read Full TranscriptLivaNova PLC investor slides for Q2/2026
Last Update: Aug 05, 2026
See full investor slides
Earnings
Latest Release
Aug 05, 2026
EPS / Forecast
1.26 / 1.09
Revenue / Forecast
390.6M / 380.57M
Compare LIVN to Peers and Sector
Metrics to compare | LIVN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLIVNPeersSector | |
|---|---|---|---|---|
P/E Ratio | 21.8x | 16.6x | −0.4x | |
PEG Ratio | 0.12 | 0.19 | 0.00 | |
Price / Book | 3.1x | 2.2x | 2.6x | |
Price / LTM Sales | 2.8x | 1.8x | 3.0x | |
Upside (Analyst Target) | 19.3% | 37.9% | 56.4% | |
Fair Value Upside | Unlock | 11.3% | 7.9% | Unlock |
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals; and devices that deliver neuromodulation therapy for treating drug-resistant epilepsy and depression. This segment also includes the development and clinical testing of aura6000 system for treating obstructive sleep apnea. It serves perfusionists, neurologists, neurosurgeons, hospitals, other healthcare professionals and medical institutions, and healthcare providers. The company sells its medical devices through direct sales representatives, agents, and independent distributors in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. LivaNova PLC was incorporated in 2015 and is headquartered in Gloucester, the United Kingdom.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the LivaNova PLC (LIVN) Stock Price Today?
The LivaNova PLC stock price today is 75.68 USD.
What Stock Exchange Does LivaNova PLC Trade On?
LivaNova PLC is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for LivaNova PLC?
The stock symbol for LivaNova PLC is "LIVN."
What Is the LivaNova PLC Market Cap?
As of today, LivaNova PLC market cap is 4.12B USD.
What Is LivaNova PLC's Earnings Per Share (TTM)?
The LivaNova PLC EPS (TTM) is 3.40.
When Is the Next LivaNova PLC Earnings Date?
LivaNova PLC will release its next earnings report on Nov 04, 2026.
From a Technical Analysis Perspective, Is LIVN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has LivaNova PLC Stock Split?
LivaNova PLC has split 0 times.
How Many Employees Does LivaNova PLC Have?
LivaNova PLC has 3300 employees.
What is the current trading status of LivaNova PLC (LIVN)?
As of Oct 02, 2026, LivaNova PLC (LIVN) is trading at a price of 75.68 USD, with a previous close of 74.70 USD. The stock has fluctuated within a day range of 75.68 USD to 75.68 USD, while its 52-week range spans from 48.82 USD to 85.76 USD.
What Is LivaNova PLC (LIVN) Price Target According to Analysts?
The average 12-month price target for LivaNova PLC is 89.10 USD, with a high estimate of 100 USD and a low estimate of 75 USD. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +17.73% Upside potential.
What Is the LIVN Premarket Price?
LIVN's last pre-market stock price is 75.25 USD. The pre-market share volume is 30.00, and the stock has decreased by 0.55, or 0.74%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.